Atea Pharmaceuticals's top three insider shareholders as of March 23, 2026 are Jean-Pierre Sommadossi (President, Ceo, And Chairman, 5.87Mn shares), Jean-Pierre Sommadossi (President, Ceo, And Chairman, 767.83K shares), Andrea Corcoran (See Remarks, 763.58K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jean-Pierre Sommadossi | President, Ceo, And Chairman | 0 | 5,866,025 | 19 Sep, 2024 |
| Andrea Corcoran | See Remarks | 823,576 | 0 | 13 Mar, 2026 |
| Jean-Pierre Sommadossi | President, Ceo, And Chairman | 767,830 | 0 | 03 Feb, 2026 |
| Franklin M Berger | 506,497 | 0 | 24 Jun, 2025 | |
| Janet Mj Hammond | Chief Development Officer | 127,665 | 0 | 03 Feb, 2026 |
| Bruno Lucidi | 112,750 | 0 | 24 Jun, 2025 | |
| Maria Arantxa Horga | Chief Medical Officer | 96,086 | 0 | 03 Feb, 2026 |
| Bruce Polsky | 95,206 | 0 | 24 Jun, 2025 | |
| Polly A. Murphy | 86,045 | 0 | 24 Jun, 2025 | |
| John Vavricka | Chief Commercial Officer | 82,594 | 0 | 03 Feb, 2026 |
| Wayne Foster | Evp, Chief Accounting Officer | 79,329 | 0 | 03 Feb, 2026 |
| Barbara Gayle Duncan | 62,750 | 0 | 24 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Mar, 2026 | Andrea Corcoran | Common Stock | A | 60,000 | $1.24 | 823,576 | D | M |
| 11 Mar, 2026 | Andrea Corcoran | Stock Option (Right to Buy) | A | 60,000 | $0.00 | 0 | D | M |
| 31 Jan, 2026 | Jean-Pierre Sommadossi | Common Stock | A | 272,983 | - | 573,923 | D | M |
| 31 Jan, 2026 | John Vavricka | Common Stock | A | 42,083 | - | 94,164 | D | M |
| 31 Jan, 2026 | Maria Arantxa Horga | Common Stock | A | 51,283 | - | 112,159 | D | M |
| 31 Jan, 2026 | Andrea Corcoran | Common Stock | A | 54,866 | - | 779,680 | D | M |
| 31 Jan, 2026 | Janet Mj Hammond | Common Stock | A | 58,050 | - | 141,801 | D | M |
| 31 Jan, 2026 | Wayne Foster | Common Stock | A | 41,333 | - | 91,461 | D | M |
| 31 Jan, 2026 | John Vavricka | Common Stock | D | 11,570 | $4.24 | 82,594 | D | F |
| 31 Jan, 2026 | Andrea Corcoran | Common Stock | D | 16,104 | $4.24 | 763,576 | D | F |
| 31 Jan, 2026 | Maria Arantxa Horga | Common Stock | D | 16,073 | $4.24 | 96,086 | D | F |
| 31 Jan, 2026 | Wayne Foster | Common Stock | D | 12,132 | $4.24 | 79,329 | D | F |
| 31 Jan, 2026 | Janet Mj Hammond | Common Stock | D | 14,136 | $4.24 | 127,665 | D | F |
| 31 Jan, 2026 | Jean-Pierre Sommadossi | Common Stock | D | 106,093 | $4.24 | 467,830 | D | F |
| 31 Jan, 2026 | Wayne Foster | Restricted Stock Units | D | 33,333 | $0.00 | 0 | D | M |
| 03 Feb, 2026 | Jean-Pierre Sommadossi | Common Stock | A | 300,000 | $1.24 | 767,830 | D | M |
| 31 Jan, 2026 | Janet Mj Hammond | Restricted Stock Units | D | 46,800 | $0.00 | 0 | D | M |
| 31 Jan, 2026 | Andrea Corcoran | Restricted Stock Units | D | 44,366 | $0.00 | 0 | D | M |
| 31 Jan, 2026 | Maria Arantxa Horga | Restricted Stock Units | D | 41,533 | $0.00 | 0 | D | M |
| 31 Jan, 2026 | John Vavricka | Restricted Stock Units | D | 33,333 | $0.00 | 0 | D | M |